Gene: GREP1
Official Full Name: glycine rich extracellular protein 1provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17253 | GREP1 Knockout cell line (HeLa) | Human | GREP1 | 1:3~1:6 | Negative | Online Inquiry |
KO17254 | GREP1 Knockout cell line (HCT 116) | Human | GREP1 | 1:2~1:4 | Negative | Online Inquiry |
KO17255 | GREP1 Knockout cell line (HEK293) | Human | GREP1 | 1:3~1:6 | Negative | Online Inquiry |
KO17256 | GREP1 Knockout cell line (A549) | Human | GREP1 | 1:3~1:4 | Negative | Online Inquiry |
GREP1 Gene Knockout Cell Lines are meticulously engineered cellular models designed to facilitate the study of the GREP1 gene, which plays a crucial role in various physiological and pathological processes. These cell lines have been developed using advanced CRISPR-Cas9 technology, allowing for precise and efficient disruption of the GREP1 gene, resulting in its functional inactivation. By creating a controlled environment where the GREP1 gene is absent, researchers can investigate the gene’s role in cellular mechanisms such as signal transduction, gene expression regulation, and response to environmental stressors.
The mechanisms underlying the functionality of these knockout cell lines are grounded in the principles of gene expression regulation and cellular signaling pathways. By observing the phenotypic and genotypic changes post-knockout, scientists can uncover important relationships between GREP1 and various biological processes. This has widespread implications in fields such as cancer research, regenerative medicine, and developmental biology, providing valuable insights into how the absence of GREP1 can alter cellular behavior and contribute to disease states.
One of the key advantages of GREP1 Gene Knockout Cell Lines is their unparalleled specificity and reliability compared to alternative methods, such as siRNA knockdown or pharmacological inhibition, which may yield transient effects or off-target consequences. With these cell lines, researchers gain a robust tool that offers reproducible results and the ability to carry out long-term studies.
The value of GREP1 Gene Knockout Cell Lines extends to both academic and clinical researchers, empowering them to deepen their understanding of GREP1-related mechanisms in health and disease. Furthermore, these cell lines enhance the ability to screen potential therapeutic targets and evaluate drug efficacy in a controlled experimental context.
Our company specializes in high-quality, state-of-the-art biological products, ensuring that our offerings meet the rigorous demands of modern scientific investigation. With a commitment to excellence and innovation, we are dedicated to supporting the scientific community's quest for knowledge and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.